Clinical Trials Browser

Phase 3 × ledipasvir, sofosbuvir drug combination × 90 days × Clear all

NCT02771405 2026-04-13

FRI-STC

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic